Cargando…
Acute and Subacute Stent Thrombosis in a Patient With Clopidogrel Resistance: A Case Report
Drug-eluting stents (DES) are considered the treatment of choice for most patients with obstructive coronary artery disease when percutaneous intervention (PCI) is feasible. However, stent thrombosis seems to occur more frequently with DES and occasionally is associated with resistance to anti-plate...
Autores principales: | Kim, Sung Soo, Jeong, Myung Ho, Kim, Hyun-Kuk, Bae, Soo Young, Ryu, Kyoung Ho, Cho, Kyung Hun, Kim, Min Chul, Park, Keun Ho, Sim, Doo Sun, Hong, Young Joon, Kim, Ju Han, Ahn, Youngkeun, Kang, Jung Chaee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771795/ https://www.ncbi.nlm.nih.gov/pubmed/19949590 http://dx.doi.org/10.4070/kcj.2009.39.10.434 |
Ejemplares similares
-
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011) -
Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009) -
Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019) -
Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011) -
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)